uniQure
QURE
#5325
Rank
C$2.31 B
Marketcap
C$33.42
Share price
0.39%
Change (1 day)
-56.36%
Change (1 year)

Earnings for uniQure (QURE)

Earnings in 2026 (TTM): -C$0.35 Billion

According to uniQure's latest financial reports the company's current earnings are C$18.67 Million. In 2025 the company made an earning of -C$0.28 Billion, an increase over its 2024 earnings that were of -C$0.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for uniQure from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.35 Billion24.36%
2025 -C$0.28 Billion-18.47%
2024 -C$0.34 Billion-22.65%
2023 -C$0.44 Billion139.01%
2022 -C$0.19 Billion-138.54%
2021 C$0.47 B-335.29%
2020 -C$0.21 Billion13.88%
2019 -C$0.18 Billion49.51%
2018 -C$0.12 Billion4.55%
2017 -C$0.12 Billion12.65%
2016 -C$0.11 Billion-9.59%
2015 -C$0.12 Billion66.95%
2014 -C$66.58 Million30.8%
2013 -C$50.9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
C$14.65 B-4,295.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.20 B-3,020.54%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
-C$0.16 Billion-55.00%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
-C$0.29 Billion-18.50%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.21 B-160.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-C$0.98 Billion 179.25%๐Ÿ‡บ๐Ÿ‡ธ USA